Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Oncology (Williston Park, N.Y.)|February 3, 2005
Adjuvant chemotherapy for early-stage breast cancer: the tAnGo trialChristopher Poole
Journal of Elder Abuse & Neglect|April 5, 2012
Intimate partner victimization among adults aged 60 and older: an analysis of the 1999 and 2004 General Social SurveyChristopher Poole, John Rietschlin
Nature Reviews. Clinical Oncology|July 11, 2012
Thrombosis and cancerAnnie Young, Oliver Chapman, Carole Connor, et al.
Cornea|March 4, 2016
Development of a Novel Technique to Measure Corneal Nerve Migration RateKatie Edwards, Nicola Pritchard, Christopher Poole, et al.
International Journal of Radiation Oncology, Biology, Physics|August 25, 2014
Natural oil-based emulsion containing allantoin versus aqueous cream for managing radiation-induced skin reactions in patients with cancer: a phase 3, double-blind, randomized, controlled trialRaymond Javan Chan, Jennifer Mann, Lee Tripcony, et al.
International Journal of Sports Medicine|October 2, 2017
Time Course Change in Muscle Swelling: High-Intensity vs. Blood Flow Restriction ExerciseEduardo D S Freitas, Christopher Poole, Ryan M Miller, et al.
Diagnostics (Basel, Switzerland)|November 27, 2024
Four-Dimensional Flow MRI for Cardiovascular Evaluation (4DCarE): A Prospective Non-Inferiority Study of a Rapid Cardiac MRI Exam: Study Protocol and Pilot AnalysisJiaxing Jason Qin, Mustafa Gok, Alireza Gholipour, et al.
Cancer Chemotherapy and Pharmacology|April 6, 2002
Effect of renal impairment on the pharmacokinetics and tolerability of capecitabine (Xeloda) in cancer patientsChristopher Poole, Jill Gardiner, Chris Twelves, et al.
Cornea|June 17, 2016
Repeatability of Measuring Corneal Nerve Migration Rate in Individuals With and Without DiabetesKhaled Al Rashah, Nicola Pritchard, Cirous Dehghani, et al.
Advances in Therapy|August 25, 2011
Insulin therapy in diabetes and cancer risk: current understanding and implications for future study: proceedings from a meeting of a European Insulin Safety Consensus Panel, convened and sponsored by Novo Nordisk, held Tuesday October 5, 2010 at The Radisson Edwardian Heathrow Hotel, Hayes, Middlesex, UKStephen C L Gough, Cristóbal Belda-Iniesta, Christopher Poole, et al.
Pageof 3